Evaluation of Real-Life Investigational Use of Enoximone in Asthma, the Third Step in Drug Repurposing: A Preliminary Report

BACKGROUND: The population of uncontrolled asthma patients represents a large therapeutic burden. The PDE3-inhibitor enoximone is a strong and quick bronchodilator and is known to successfully treat life-threatening bronchial asthma (status asthmaticus). Translational mice models showed anti-inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Beute, Jan, Boermans, Pieter, KleinJan, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575614/
https://www.ncbi.nlm.nih.gov/pubmed/34760031
http://dx.doi.org/10.1155/2021/7456208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575614/
https://www.ncbi.nlm.nih.gov/pubmed/34760031
http://dx.doi.org/10.1155/2021/7456208

Ejemplares similares